MONDAY, June 13, 2022 (HealthDay News) — An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effectiveness. A condition of Health Canada’s approval of Albrioza (AMX0035)Continue Reading
MONDAY, May 23, 2022 (HealthDay News) — The anti-inflammatory benefits of a common gout medicine may help save the lives of heart failure patients, researchers say. The medication, colchicine, could also reduce the risk of heart attack and stroke in patients whose arteries are clogged with cholesterol, according to theContinue Reading
THURSDAY, May 12, 2022 (HealthDay News) — An international research effort has unveiled the most extensive reference map yet of individual cells within the human body, knowledge that could revolutionize the study of health and disease. The massive Human Cell Atlas contains detailed maps of more than one million individualContinue Reading
WEDNESDAY, May 4, 2022 (HealthDay News) — Despite what you may have heard, rats and other city wildlife aren’t likely to trigger future pandemics in people, according to a new study. The COVID-19 pandemic has scientists trying to determine where future outbreaks are most likely to start. It’s long beenContinue Reading
THURSDAY, March 31, 2022 (HealthDay News) — In a close vote, an advisory panel for the U.S. Food and Drug Administration decided not to recommend the approval of an experimental drug for the deadly neurological disease amyotrophic lateral sclerosis (ALS). The panel’s decision had been closely watched, with patient advocacyContinue Reading
TUESDAY, March 29, 2022 (HealthDay News) — Despite months of intense lobbying by patient advocates, federal health officials on Monday posted a largely negative review of an experimental drug for the devastating illness known as amyotrophic lateral sclerosis (ALS). In an analysis of Amylyx Pharmaceuticals’ drug, known for now onlyContinue Reading
MONDAY, March 28, 2022 (HealthDay News) — Advocacy groups are pressing U.S. federal regulators to fast-track approval of an experimental drug treatment for the deadly neurological disease ALS (amyotrophic lateral sclerosis), with a decision expected this week. The push to approve the drug, so far just called AMX0035, is basedContinue Reading
TUESDAY, March 22, 2022 (HealthDay News) — Unable to move a single muscle, even to open your eyes. Completely locked into your own body, yet fully conscious and aware. Lou Gehrig’s disease — amyotrophic lateral sclerosis (ALS) — is a nightmare in its advanced form, leaving patients without any meansContinue Reading
THURSDAY, Jan. 27, 2022 (HealthDay News) — Taking vitamin D supplements may help stave off psoriasis, rheumatoid arthritis, lupus and other autoimmune diseases, a new study suggests. Previous research has hinted at this connection, but the new study is the first randomized controlled trial to look at what happens whenContinue Reading
WEDNESDAY, Jan. 26, 2022 (HealthDay News) — A one-two punch from science has clearly tagged the mononucleosis virus, Epstein-Barr, as a major cause of multiple sclerosis. The Epstein-Barr virus (EBV) appears to trigger multiple sclerosis (MS) by tricking the immune systems of some into attacking their body’s own nerve cells,Continue Reading